Insider trading on July 24, 2026
29 insiders at 26 companies bought $96.9M of their own stock on the open market, across 45 transactions. The largest was Aghazadeh Behzad, Director, 10% Owner, buying $35M of Scribe Therapeutics, Inc. (SCTX).
12 chief executives bought: Huang Jack Jiajia at COE, Semple Christopher James at Crestline Lending Solutions, LLC, Patel Snehal at GLSI and 9 more.
Insiders sold $117.3M across 150 open-market sales. That is 1.2× the value bought. Selling routinely outweighs buying, because most executive pay is delivered in stock.
Open-market purchases
Code P only — insiders spending their own money, largest first.
Open-market sales
Pre-arranged 10b5-1 trades are marked.